Top Markets
Coin of the day
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
Clasificación en acciones #33550
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Precio por acción
$0.11989842
Capitalización bursátil
$7.42M
Cambio (1 día)
6.25%
Cambio (1 año)
179.27%
País
AU
Comercio Vectus Biosystems Limited (VBS)

Categoría

Historial de desdoblamientos de acciones de Vectus Biosystems Limited (VBS)
La acción Vectus Biosystems Limited (símbolo: VBS) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 17, 2026.
Una acción VBS comprada antes de Aug 17, 2026 equivaldría hoy a 0 acciones VBS.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE